Upgrade to SI Premium - Free Trial

Citi Resumes Tenet Healthcare (THC) at Buy

July 23, 2021 8:45 AM

Citi analyst Ralph Giacobbe resumes coverage on Tenet Healthcare (NYSE: THC) with a Buy rating.


For an analyst ratings summary and ratings history on Tenet Healthcare click here. For more ratings news on Tenet Healthcare click here.


Shares of Tenet Healthcare closed at $70.00 yesterday.

Categories

New Coverage

Next Articles